Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
43.69
-0.65 (-1.47%)
At close: Nov 16, 2026, 4:00 PM EST
43.48
-0.21 (-0.48%)
Pre-market: Nov 17, 2026, 4:06 AM EST

Boston Scientific Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6091,9654148659281,925
Cash & Short-Term Investments
6091,9654148659281,925
Cash Growth
-52.23%374.64%-52.14%-6.79%-51.79%11.02%
Accounts Receivable
3,1132,9262,5582,2281,9701,778
Receivables
3,1132,9262,5582,2281,9701,778
Inventory
3,3172,9432,8102,4841,8671,610
Restricted Cash
5880111130149188
Other Current Assets
1,0678801,027807846816
Total Current Assets
8,1648,7946,9206,5145,7606,317
Property, Plant & Equipment
4,7204,5013,7433,2982,8322,687
Long-Term Investments
2,292682555413407411
Goodwill
18,73618,28217,08914,38712,92011,988
Other Intangible Assets
6,8607,0196,6846,0035,9696,235
Long-Term Deferred Tax Assets
3,8403,6753,6553,8413,9424,142
Other Long-Term Assets
849720749680639449
Total Assets
45,46143,67339,39535,13632,46932,229

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,2501,144960942862794
Accrued Expenses
2,9693,2012,7732,1361,8551,883
Current Portion of Long-Term Debt
1,0442991,77853120261
Current Portion of Leases
-9081766171
Current Income Taxes Payable
---220232209
Current Unearned Revenue
-313306266220208
Other Current Liabilities
719392501762553848
Total Current Liabilities
5,9825,4396,3994,9333,8034,274
Long-Term Debt
10,78511,0128,8428,5668,9108,798
Long-Term Leases
124571527395352395
Long-Term Unearned Revenue
-369329311289276
Long-Term Deferred Tax Liabilities
264220155134144310
Other Long-Term Liabilities
2,4331,5901,1401,2671,3981,554
Total Liabilities
19,58819,20117,39215,60614,89615,607

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
181717171717
Additional Paid-In Capital
21,88121,50521,05620,64720,28919,986
Retained Earnings
8,4005,5712,673819-750-1,392
Treasury Stock
-4,318-2,251-2,251-2,251-2,251-2,251
Comprehensive Income & Other
-351-60927550268262
Total Common Equity
25,63024,23321,77019,28217,57316,622
Minority Interest
243239233248--
Shareholders' Equity
25,87324,47222,00319,53017,57316,622
Total Liabilities & Equity
45,46143,67339,39535,13632,46932,229

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
11,95311,97211,2289,5689,3439,525
Net Cash (Debt)
-11,344-10,007-10,814-8,703-8,415-7,600
Net Cash Growth
------
Net Cash Per Share
-7.67-6.70-7.28-5.95-5.84-5.30
Filing Date Shares Outstanding
1,4491,4841,4761,4671,4351,427
Total Common Shares Outstanding
1,4491,4831,4751,4661,4331,426
Working Capital
2,1823,3555211,5811,9572,043
Book Value Per Share
17.6816.3414.7613.1612.2611.66
Tangible Book Value
34-1,068-2,003-1,108-1,316-1,601
Tangible Book Value Per Share
0.02-0.72-1.36-0.76-0.92-1.12
Land
185173144140137109
Buildings
2,7432,4852,0181,8431,6951,523
Machinery
4,1303,8273,6303,5033,2983,288
Construction In Progress
9761,1611,035857598605
SEC Filings: 10-K · 10-Q